Abstract
The gold standard for diagnosis of arrhythmia-induced syncope is correlation of abnormal ECG findings of spontaneous cardiac arrhythmias with symptoms (i.e., syncope). Obtaining such documentation is usually best achieved by ambulatory electrocardiographic (ECG) recording (e.g., “Holter” monitors, “event” recorders, mobile cardiac outpatient telemetry (MCOT), or insertable loop recorders (ILRs)). However, in many patients it may not be possible to obtain such documentation due to the infrequency of symptomatic events, or concerns regarding patient safety should a spontaneous recurrence be associated with a life-threatening circumstance or potential for physical injury. In such cases, electrophysiological study (EPS) may be warranted in an attempt to obtain at least a plausible cause for the symptoms. This is particularly the case in those individuals with an abnormal ECG and/or evidence underlying structural heart disease.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Moya A, et al. Guidelines for the diagnosis and management of syncope (version 2009). Eur Heart J. 2009;30:2631–2671.
Brignole M, et al. Standardized care pathway vs usual management of syncope patients presenting as emergencies at general hospitals. Europace. 2006;8:644–650.
Benditt DG, et al. Indications for electrophysiologic testing in the diagnosis and assessment of sinus node dysfunction. Circulation. 1987;75(III):93–102.
De Sisti A, et al. Electrophysiologic characteristics of the atrium in sinus node dysfunction: atrial refractoriness and conduction. J Cardiovasc Electrophysiol. 2000;11:30–33.
Yee R, Strauss HC. Electrophysiologic mechanisms: sinus node dysfunction. Circulation. 1987;75(III):12–18.
Bergfeldt L, et al. Sinus node recovery time assessment revisited: role of pharmacological blockade of the autonomic nervous system. J Cardiovasc Electrophysiol. 1996;7: 95–101.
Rothman SA, et al. The diagnosis of cardiac arrhythmias: a prospective multi-center randomized study comparing mobile cardiac outpatient telemetry versus standard loop event monitoring. J Cardiovasc Electrophysiol. 2007;18:241–247.
Narula OS, et al. Significance of the sinus-node recovery time. Circulation. 1972;45:140–148.
de Marneffe M, et al. Variations of normal sinus node function in relation to age: role of autonomic influence. Eur Heart J. 1986;7:662–666.
de Marneffe M, et al. The sinus node function: normal and pathological. Eur Heart J. 1993;14:649–654.
Brignole M. Sick sinus syndrome. Clin Geriatr Med. 2002;18:211–227.
Gann D, et al. Electrophysiologic evaluation of elderly patients with sinus bradycardia: a long-term follow-up study. Ann Intern Med. 1979;90:24–29.
Menozzi C, et al. The natural course of untreated sick sinus syndrome and identification of the variables predictive of unfavourable outcome. Am J Cardiol. 1998;82:1205–1209.
Brignole M, et al. Mechanism of syncope in patients with bundle branch block and negative electrophysiologic test. Circulation. 2001;104:2045–2050.
Menozzi C, et al. Mechanism of syncope in patients with heart disease and negative electrophysiologic test. Circulation. 2002;105:2741–2745.
Moya A, et al. Mechanism of syncope in patients with isolated syncope and in patients with tilt-positive syncope. Circulation. 2001;104:1261–1267.
Dhingra RC, et al. Significance of block distal to the His bundle induced by atrial pacing in patients with chronic bifascicular block. Circulation. 1979;60:1455–1464.
Petrac D, et al. Prospective evaluation of infrahisal second-degree AV block induced by atrial pacing in the presence of chronic bundle branch block and syncope. Pacing Clin Electrophysiol. 1996;19:679–687.
Click R, et al. Role of invasive electrophysiologic testing in patients with symptomatic bundle branch block. Am J Cardiol. 1987;59:817–823.
Gronda M, et al. Electrophysiologic study of atrio-ventricular block and ventricular conduction defects. G Ital Cardiol. 1984;14:768–773.
Dini P, et al. Prognostic value of His-ventricular conduction after ajmaline administration. In: Masoni A, Alboni P, eds. Cardiac Electrophysiology Today. London: Academic Press; 1982:pp 515–522.
Englund A, et al. Pharmacological stress testing of the His-Purkinje system in patients with bifascicular block. Pacing Cardiac Electrophysiol. 1998;21:1979–1987.
Fei L, Trohman RG. Advances in cardiac electrophysiology and pacing. Crit Care Clin. 2001;17:337–364.
Camm AJ, Lau C-P. Syncope of undetermined origin: diagnosis and management. Prog Cardiol. 1988;1:139–156.
Moss AJ, et al. ECG T-wave patterns in genetically distinct forms of the hereditary long QT syndrome. Circulation. 1995;92:2929–2934.
Zipes DP, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Circulation. 2006;114: e385–e484.
Priori S. Long QT and Brugada syndromes. From genetics to clinical management. J Cardiovasc Electrophysiol. 2000;11:1174–1180.
Lacroix D, et al. Evaluation of arrhythmic causes of syncope: correlation between Holter monitoring, electrophysiologic testing, and body surface potential mapping. Am Heart J. 1991;122:1346–1354.
Knight B, et al. Outcome of patients with nonischemic dilated cardiomyopathy and unexplained syncope treated with an implantable defibrillator. J Am Coll Cardiol. 1999;33: 1964–1970.
Link MS, et al. High incidence of appropriate implantable cardioverter-defibrillator therapy in patients with syncope of unknown etiology and inducible ventricular tachycardia. J Am Coll Cardiol. 1997;29:370–375.
Militianu A, et al. Implantable cardioverter defibrillator utilization among device recipients presenting exclusively with syncope or near-syncope. J Cardiovasc Electrophysiol. 1997;8:1087–1097.
Mittal S, et al. Long-term outcome of patients with unexplained syncope treated with an electrophysiologic-guided approach in the implantable cardioverter-defibrillator era. J Am Coll Cardiol. 1999;34:1082–1089.
Andrews N, et al. Implantable defibrillator event rates in patients with unexplained syncope and inducible sustained ventricular tachyarrhythmias. J Am Coll Cardiol. 1999;34:2023–2030.
Pires L, et al. Comparison of event rates and survival in patients with unexplained syncope without documented ventricular tachyarrhythmias versus patients with documented sustained ventricular tachyarrhythmias both treated with implantable cardioverter-defibrillator. Am J Cardiol. 2000;85:725–728.
Fonarow G, et al. Improved survival in patients with nonischemic advanced heart failure and syncope treated with an implantable cardioverter-defibrillator. Am J Cardiol. 2000;85: 981–985.
Olshansky B, et al. Syncope predicts the outcome of cardiomyopathy patients: Analysis of the SCD-HeFT study. J Am Coll Cardiol. 2008;51:1277–1282.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2011 Springer-Verlag London Limited
About this chapter
Cite this chapter
Brignole, M., Benditt, D.G. (2011). When and How: Electrophysiological Study (EPS). In: Syncope. Springer, London. https://doi.org/10.1007/978-0-85729-201-8_20
Download citation
DOI: https://doi.org/10.1007/978-0-85729-201-8_20
Published:
Publisher Name: Springer, London
Print ISBN: 978-0-85729-200-1
Online ISBN: 978-0-85729-201-8
eBook Packages: MedicineMedicine (R0)